|
Medicon Valley encompasses Skåne in southern Sweden and Copenhagen in Denmark, and is home to no less than 60 per cent of Scandinavia's biotechnology and pharmaceutical industries. More than 54,000 people in Medicon Valley work within the medical industry, including 5,000 researchers.Medicon Valley ranks number three in Europe in the biomedicine field, after London and Paris, and the region has probably the highest number of biotech companies per capita in the world. Sweden and Denmark are ranked number two and three in Europe when it comes to R&D expenditure per capita in the pharmaceutical industry, and Denmark and Sweden are, per capita, ranked number three and five in terms of world pharmaceutical exports. Medicon Valley has ample capital for biotechnology projects and also has patient investors who think long-term. In 1994, US$250 million was available to Medicon Valley. By 2000, this figure had increased to US$650 million and the invested capital in Medicon Valley was approximately US$160 million. |
